BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27531352)

  • 1. Prognostic role of microRNA-21 expression in gliomas: a meta-analysis.
    Li C; Sun J; Xiang Q; Liang Y; Zhao N; Zhang Z; Liu Q; Cui Y
    J Neurooncol; 2016 Oct; 130(1):11-17. PubMed ID: 27531352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of miR-183 expression and its clinical significance in human brain glioma.
    Ye Z; Zhang Z; Wu L; Liu C; Chen Q; Liu J; Wang X; Zhuang Z; Li W; Xu S; Hang C
    Neurol Sci; 2016 Aug; 37(8):1341-7. PubMed ID: 27215622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
    Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
    Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic role of microRNA-155 expression in gliomas: A meta-analysis.
    Zhou Y; Wang X; Liu Z; Huang X; Li X; Cheng K; Jiang X
    Clin Neurol Neurosurg; 2019 Jan; 176():103-109. PubMed ID: 30554090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
    Lai NS; Dong QS; Ding H; Miao ZL; Lin YC
    J Clin Neurosci; 2014 May; 21(5):755-60. PubMed ID: 24382515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
    J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and Prognostic Significance of CD133 in Glioma Patients: A Meta-Analysis.
    Han M; Guo L; Zhang Y; Huang B; Chen A; Chen W; Liu X; Sun S; Wang K; Liu A; Li X
    Mol Neurobiol; 2016 Jan; 53(1):720-727. PubMed ID: 25589004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis.
    Yan W; Li R; Liu Y; Yang P; Wang Z; Zhang C; Bao Z; Zhang W; You Y; Jiang T
    Oncotarget; 2014 Dec; 5(24):12908-15. PubMed ID: 25415048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAMPT, GRN, and SERPINE1 signature as predictor of disease progression and survival in gliomas.
    Vachher M; Arora K; Burman A; Kumar B
    J Cell Biochem; 2020 Apr; 121(4):3010-3023. PubMed ID: 31710121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of microRNA-124 predicts poor prognosis in glioma patients.
    Chen T; Wang XY; Li C; Xu SJ
    Neurol Sci; 2015 Jan; 36(1):131-5. PubMed ID: 25112530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas.
    Qian Z; Li Y; Fan X; Zhang C; Wang Y; Jiang T; Liu X
    J Neurooncol; 2018 Mar; 137(1):127-137. PubMed ID: 29204839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced expression of microRNA-134 correlates with malignancy and poor prognosis in human glioma.
    Zhong J; Li B
    J Clin Neurosci; 2015 Mar; 22(3):583-7. PubMed ID: 25564273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
    Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y
    Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD105 Over-expression Is Associated with Higher WHO Grades for Gliomas.
    Kong X; Wang Y; Liu S; Xing B; Yang Y; Li Y; Ren Z; Su C; Ma W; Wang R
    Mol Neurobiol; 2016 Jul; 53(5):3503-3512. PubMed ID: 26884265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ki-67 is a valuable prognostic factor in gliomas: evidence from a systematic review and meta-analysis.
    Chen WJ; He DS; Tang RX; Ren FH; Chen G
    Asian Pac J Cancer Prev; 2015; 16(2):411-20. PubMed ID: 25684464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
    He J; Deng Y; Yang G; Xie W
    J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-15a down-regulation is associated with adverse prognosis in human glioma.
    Xie T; Liu P; Chen L; Chen Z; Luo Y; Chen X; Feng Y; Luo X
    Clin Transl Oncol; 2015 Jul; 17(7):504-10. PubMed ID: 25575767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of miR-21 in gliomas: comprehensive study based on meta-analysis and TCGA dataset validation.
    Jiang G; Mu J; Liu X; Peng X; Zhong F; Yuan W; Deng F; Peng X; Peng S; Zeng X
    Sci Rep; 2020 Mar; 10(1):4220. PubMed ID: 32144351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of microRNA 221 is a poor predictor for glioma.
    Song Y; He M; Zhang J; Xu J
    Medicine (Baltimore); 2020 Dec; 99(49):e23163. PubMed ID: 33285691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
    Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
    Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.